| Literature DB >> 9070573 |
J J Goldberger1, G Horvath, S Inbar, A H Kadish.
Abstract
We evaluated the utility of performing predischarge implantable cardioverter-defibrillator (ICD) testing and ICD testing at 1 month in detecting ICD-related problems, identifying 4 patients with an unacceptable increase in defibrillation threshold. Given that ICD testing is noninvasive and has minimal (if any) associated risk, we recommend that predischarge and 1-month follow-up ICD testing should be performed after implantation.Entities:
Mesh：
Year: 1997 PMID： 9070573 DOI： 10.1016/s0002-9149(96)00882-x
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778